Ashland

Abstract In the present study, we aimed to prepare a gastroretentive drug delivery system that would be both highly resistant...

10. January 2017 Abstract: A double layer-coated colon-specific drug delivery system (DL-CDDS) was developed, which consisted of chitosan (CTN) based...

03. January 2017 Abstract Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is part of first-line therapy for the treatment...

22. November 2016 Investigation of the processing window for Affinisol and Plasdone - S630 polymers during Hot-melt extrusion (for 3D...

25. October 2016 Ashland has opened a pharmaceutical excipients plant in Nanjing, China in a bid to capture growing local...

Functionality of Benecel K4M/Carbopol 971P NF matrices in direct compression tablets for controlled release The aim of this work is...

Traditionally, the melt granulation for pharmaceutical products was performed at low temperature (<90°C) with high-shear granulators using low-melting waxy binders,...

17. July 2016 Abstract Solubility represents an important challenge for formulation of drugs, because the therapeutic efficacy of a drug...

Brussels, 17. May, 2016 EXCiPACT asbl is delighted to announce that Ashland’s Aquarius™ plant site has recently been awarded an...

09. April 2016 Sumatriptan succinate (SS) is a selective serotonin receptor agonist used for the treatment of migraine attacks, suffering...